XML 36 R25.htm IDEA: XBRL DOCUMENT v3.20.2
Share-Based Compensation
6 Months Ended
Jun. 30, 2020
Share-based Payment Arrangement [Abstract]  
SHARE-BASED COMPENSATION

18. SHARE-BASED COMPENSATION

 

The Company accounts for share-based compensation in accordance with ASC 718, Compensation – Stock Compensation. ASC 718 requires companies to measure the cost of employee and non-employee services received in exchange for an award of equity instruments, including stock options, based on the grant-date fair value of the award and to recognize it as compensation expense over the period the employee and non-employee is required to provide service in exchange for the award, usually the vesting period.

 

Share-based compensation for employees and non-employees is recorded in the Consolidated Statement of Operations as a component of general and administrative expense with a corresponding increase to additional paid-in capital in shareholders’ equity.

 

Stock Options

 

On March 20, 2019, the Company granted options outside of any equity plan to two employees and one non-employee for the purchase of an aggregate of 180,000 shares of the Company’s common stock. All the options have an exercise price of $1.06 per share and expire on March 20, 2023. Under the Black-Scholes option pricing model, the fair value of the 180,000 options on the date of grant was estimated at $123,130.

 

No options were granted during the six months ended June 30, 2020.

 

The following table summarizes the assumptions used to estimate the fair value of stock options granted during the period January 10, 2019 (inception) to June 30, 2019:

 

   2019 
Expected dividend yield   0%
Expected volatility   90%
Risk-free interest rate   2.40-2.47%
Expected life of options   4.0 years 

   

The following table represents stock option activity for the six months ended June 30, 2020 and the period January 10, 2019 (Inception) to June 30, 2019:

 

   Number of
Options
   Weighted-
Average
Exercise
Price per
Share
   Weighted-
Average
Contractual
Life in
Years
   Aggregate
Intrinsic
Value
 
Outstanding – December 31, 2019   8,695,000   $0.63    1.34   $2,264,760 
Granted                
Exercised                
Cancelled or Expired   (3,630,000)   0.61         
Outstanding – June 30, 2020   5,065,000   $0.65    1.69   $2,191,750 
Exercisable – June 30, 2020   5,065,000   $0.65    1.69   $2,191,750 

 

   Number of
Options
   Weighted-
Average
Exercise
Price per
Share
   Weighted-
Average
Contractual
Life in
Years
   Aggregate
Intrinsic
Value
 
Outstanding – January 10, 2019   13,990,000   $0.61    3.15   $ 
Granted   180,000    1.06         
Exercised                
Cancelled or Expired   (50,000)   0.90         
Outstanding – June 30, 2019   14,120,000   $0.61    1.57   $4,466,080 
Exercisable – June 30, 2019   13,745,000   $0.60    1.56   $4,466,080 

 

For the six months ended June 30, 2020, there were no unvested stock options.

 

The Company did not record any share-based compensation expense for the six months ended June 30, 2020. Compensation expense related to stock options is recorded in share-based compensation expense in the Consolidated Statement of Operations. For the six months ended June 30, 2020 and the period January 10, 2019 (Inception) to June 30, 2019, there was no unrecognized compensation expense related to stock options.

 

Restricted Stock Awards

 

On March 25, 2019, ComSovereign Corp.’s Board of Directors granted an aggregate of 80,000 restricted stock awards (“RSAs”) to a non-employee for consulting services, of which 60,000 RSAs immediately vested and 20,000 RSAs vested upon the change in control of ComSovereign in connection with the ComSovereign Acquisition. The grant date fair value of these RSAs was $4.40 per share of common stock for a total value of $352,000. ComSovereign recognized the full $352,000 of stock compensation expense for the RSAs during the period January 10, 2019 (inception) to March 31, 2019. ComSovereign Corp. did not recognize any additional stock compensation expense related to RSAs during the three months ended June 30, 2019.

 

For the six months ended June 30, 2020, the Company did not recognize any expense related to RSAs. For the period January 10, 2019 (Inception) through June 30, 2019, the Company recognized $62,500 compensation expense related to RSAs. See Note 1 – Description of Business and Basis of Presentation for information about the shares issued in connection with the formation of ComSovereign.

 

2020 Long-Term Incentive Plan

 

On April 22, 2020, the Company’s Board of Directors adopted the 2020 Long-Term Incentive Plan (the “2020 Plan”) which was approved by the stockholders on or about May 6, 2020. Employees, officers, directors and consultants that provide services to the Company or one of its subsidiaries may be selected to receive awards under the 2020 Plan. Awards under the 2020 Plan may be in the form of incentive or nonqualified stock options, stock appreciation rights, stock bonuses, restricted stock, stock units and other forms of awards including cash awards and performance-based awards.

 

A total of 10,000,000 shares of the Company’s common stock are authorized for issuance with respect to awards granted under the 2020 Plan. Any shares subject to awards that are not paid, delivered or exercised before they expire or are cancelled or terminated, or fail to vest, as well as shares used to pay the purchase or exercise price of awards or related tax withholding obligations, will become available for other award grants under the 2020 Plan. As of August 15, 2020, no stock grants had been issued under the 2020 Plan, and 10,000,000 shares authorized under the 2020 Plan remained available for award purposes.

 

The 2020 Plan will terminate on May 1, 2030. The maximum term of options, stock appreciation rights and other rights to acquire common stock under the 2020 Plan is ten years after the initial date of the award.